Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Recalling firm

Teva Pharmaceuticals USA

NDC code

0591-3525-11

Origin

PA, United States

Initiated by

Voluntary: Firm initiated

FDA recall number

D-0857-2018

Other Lidocaine recalls

See all

Class II · Moderate risk Ongoing Jul 16, 2026

Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile…

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0729-2026

Class II · Moderate risk Ongoing Jul 16, 2026

Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile…

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0728-2026

Class II · Moderate risk Ongoing Jul 16, 2026

Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial, Rx only, Sterile…

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0726-2026

Class III · Low risk Ongoing Jul 15, 2026

Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by…

Reason Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Asclemed USA Inc. D-0713-2026

Class II · Moderate risk Ongoing Jun 8, 2026

Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance…

Reason Lack of Assurance of Sterility

Asclemed USA Inc. D-0659-2026